Percheron Therapeutics Ltd (ASX:PER – Get Free Report) insider Ben Price acquired 5,000,000 shares of the company’s stock in a transaction that occurred on Monday, March 31st. The shares were acquired at an average cost of A$0.01 ($0.01) per share, with a total value of A$60,000.00 ($37,974.68).
Percheron Therapeutics Stock Performance
Percheron Therapeutics Company Profile
Pernod Ricard SA produces and sells wines and spirits worldwide. It offers its products under various brands. The company was founded in 1805 and is headquartered in Paris, France.
Read More
- Five stocks we like better than Percheron Therapeutics
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Which Wall Street Analysts are the Most Accurate?
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Percheron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Percheron Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
